Results 241 to 250 of about 242,782 (295)

Advances in Bioprinting to Model Immune‐Mediated Skin Diseases

open access: yesAdvanced Healthcare Materials, EarlyView.
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández   +4 more
wiley   +1 more source

High-throughput screening and characterization of novel inhibitors targeting HIV-1 protease precursor autoprocessing. [PDF]

open access: yesSci Rep
Jeep RH   +9 more
europepmc   +1 more source

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

open access: yesAdvanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales   +11 more
wiley   +1 more source

LigHTS: Massively Parallel Biomimetic Photo-Functionalization for Imaging-Based Ultra-High-Throughput Screening

open access: yes
Enrico A   +7 more
europepmc   +1 more source

Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening. [PDF]

open access: yesSLAS Discov
Lin   +7 more
europepmc   +1 more source

High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase. [PDF]

open access: yesACS Chem Biol
Aquilanti E   +8 more
europepmc   +1 more source

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma. [PDF]

open access: yesCancer Biol Ther
Danks MR   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy